Janssen Pharmaceuticals Recalls Two Oral Contraceptive Formulations Due To Instruction Errors.

reports, “Janssen Pharmaceuticals has issued a voluntary recall involving two of its oral contraceptive formulations because the patient information inside the affected packages does not include appropriate instructions for the dispenser included in the products.” This could possibly result in women “mistakenly taking an inactive ‘reminder’ pill instead of an active pill, potentially leading to breakthrough bleeding or an unintended pregnancy.” Issued Nov. 2, the “pharmacy-level recall...affects one lot of Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) tablets and two lots of Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol) tablets.” https://login.medscape.com/login/sso/getlogin?urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL3ZpZXdhcnRpY2xlLzkwNDQ1MA==&ac=401